BMI ≥27 kg/m², or type 2 diabetes? No
bmi-underNo one has reached this rule yetNot indicated — every trial in this class enrolled above that threshold
No clinician has signed off this rule yet. It reflects our reading of the guidelines cited below, which has not been independently checked.
Word for word, as generated for the example person below. Figures in the text are theirs.
Your BMI is 24.1, below the 27 threshold used in the approved indication and in the trials. This class isn't indicated for you on weight grounds.
Every cardiovascular outcome trial in this class enrolled people either with type 2 diabetes or with a BMI of 27 or above. Nothing is known about whether these drugs help a person of normal weight without diabetes, and they are not approved for it.
Guideline consensusRecommended by the guideline writing committee, drawing on trials plus expert judgement where trials run out.· checked 2026-09-12
SELECT trial — semaglutide 2.4 mg in overweight/obesity with established CVD, without diabetes · Not indicated
“Low risk, nothing flagged” — an illustrative profile, not a real user.
Cited by the recommendations above.
For practising clinicians. Endorse it, propose a change, or dispute it. We verify every reviewer before a review is shown, and a review stays attached to the version of the rule you saw — if the rule changes, the page says so. You'll be asked to declare any relevant interests; they're shown with your review.
Log in or create an account to submit a review. An account is how we tie a review to a person we can verify.
Runs in lib/engine/glp1Pathway.ts as bmi-under.